Xueqi Peng

机构：Shandong University

发表论文 6 篇 · 总被引 196 次 · h-index 5

代表论文

• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance (2024 · Cell Reports Medicine · 被引 58)
• Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models (2023 · Science Translational Medicine · 被引 55)
• Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes (2021 · Cellular and Molecular Immunology · 被引 47)
• Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response (2023 · Cell Death and Differentiation · 被引 23)
• Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure (2022 · ACS Applied Materials & Interfaces · 被引 13)
• Tim-3 facilitates dendritic cell ferroptosis and impairs antitumor immunity in steatohepatitis-related HCC (2026 · Journal of Hepatology)